Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD
Nephrology Dialysis Transplantation, 04/20/2012Ennis J et al.
Parathyroid hormone (PTH) rises with progressive chronic kidney disease (CKD) stage far more in African–American than in non–AA patients, and only a moderate component of the rise in PTH is explained by changes in serum calcium, phosphorus and 25–hydroxyvitamin in either group.
The authors performed a cross-sectional analysis of initial laboratory data collected on 2028 CKD patients (505 AA) from US practices using a laboratory CKD service.
Serum calcium (Ca), phosphorus (P), 25-hydroxyvitamin D (25-D) and plasma PTH levels were compared between the two groups.
Mean PTH for AA exceeded PTH for non-AA in Stages 2–5 (P < 0.001, all four stages).
25-D levels were higher for non-AA in Stages 1–3 (P < 0.001).
Serum Ca and P did not differ between groups at any stage. Full adjustment for these variables using multivariable generalized linear modeling did not remove the effect of AA race: AA PTH values exceeded non-AA values in CKD Stages 2–5 (P < 0.02, all four stages).
Serum Ca, P and 25-D were all inversely correlated with PTH levels irrespective of race, but all factors combined accounted for ~42% of the variance in PTH.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.